CIK 0001882782 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-20 | 8-K | 8-K items 7.01,9.01 | 2026-10-20 |
| 2026-09-09 | 8-K | 8-K items 7.01,9.01 | 2026-09-08 |
| 2026-08-06 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-04 | 8-K | 8-K items 2.02,9.01 | 2026-08-04 |
| 2026-06-23 | 8-K | 8-K items 7.01,9.01 | 2026-06-23 |
| 2026-06-17 | 10-Q | 10-Q | 2026-03-31 |
| 2026-06-17 | 8-K | 8-K items 2.02,9.01 | 2026-06-17 |
| 2026-06-05 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-05-18 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-05-18 | SCHEDULE 13D | SCHEDULE 13D | |
| 2026-05-18 | SCHEDULE 13D | SCHEDULE 13D | |
| 2026-05-15 | SCHEDULE 13D | SCHEDULE 13D | |
| 2026-05-15 | SCHEDULE 13D | SCHEDULE 13D | |
| 2026-05-13 | 4 | FORM 4 | 2026-05-11 |
| 2026-05-12 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2026-05-08 |
| 2026-05-12 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 2026-05-07 |
| 2026-05-11 | 4 | 4 | 2026-05-11 |
| 2026-05-11 | 4 | 4 | 2026-05-07 |
| 2026-05-11 | 4 | 4 | 2026-05-08 |
| 2026-05-11 | 4 | 4 | 2026-05-11 |
| 2026-05-11 | 4 | 4 | 2026-05-07 |
| 2026-05-11 | 4 | 4 | 2026-05-07 |
| 2026-05-11 | 4 | 4 | 2026-05-11 |
| 2026-05-11 | 4 | 4 | 2026-05-07 |
| 2026-05-11 | 4 | 4 | 2026-05-07 |
Forms on file (last 1,000): 3 19, 4 15, 8-K 6, SCHEDULE 13D 4, DRS/A 4, D 4, 10-Q 2, SCHEDULE 13G 2. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ODTX (0.002 USD), /gw/filings/filings?ticker=ODTX&form=8-K, /gw/filings/facts?ticker=ODTX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange